Keros Plummets 77% After Unexpected Side Effects 'Shock' Its Lead Drug
Keros Therapeutics stock plummeted Thursday after the company stopped giving higher doses in a lung disease study due to side effects. The post Keros Plummets 77% After Unexpected Side Effects 'Shock' Its Lead Drug appeared first on Investor's Business Daily.
Keros Therapeutics stock plummeted Thursday after the company stopped giving higher doses in a lung disease study due to side effects.
The post Keros Plummets 77% After Unexpected Side Effects 'Shock' Its Lead Drug appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
